publication venue for
- CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. 2023
- TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. 2023
- Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.. 15. 2023
- Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.. 13. 2021
- Bevacizumab in metastatic breast cancer: when may it be used?. 3. 2011
- Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective.. 3. 2011
- The HER2-low revolution in breast oncology: steps forward and emerging challenges. 2023
- Cell therapies in ovarian cancer. 2021